Christopher G. Parker, Andrea Galmozzi, Yujia Wang, Bruno E. Correia, Kenji Sasaki, Christopher M. Joslyn, Arthur S. Kim, Cullen L. Cavallaro, R. Michael Lawrence, Stephen R. Johnson, IƱigo Narvaiza, Enrique Saez, Enrique Saez,Enrique Saez, Benjamin F. Cravatt6, Benjamin F. Cravatt
DOI: 10.1016/j.cell.2016.12.029
A blog highlighting recent publications in the area of covalent modification of proteins, particularly relating to covalent-modifier drugs. @CovalentMod on Twitter, @covalentmod@mstdn.science on Mastodon, and @covalentmod.bsky.social on BlueSky
A covalent PFKL activator suppresses tumor growth
Jiang, X.; Lynch, E. M.; Lyu, C.; Wilson, C. N.; Salay, L. E.; Hess, H. T.; Lyons, S. N.; Lu, M.-J.; Luo, S.; Kim, G.; Chan, H.-R.; Wolfe, W...
-
Design, synthesis and biological evaluation of the activity-based probes for FGFR covalent inhibitorDandan Zhu, Zijian Zheng, Huixin Huang, Xiaojuan Chen, Shuhong Zhang, Zhuchu Chen, Ting Liu, Guangyu Xu, Ying Fu, Yongheng Chen, European Jo...
-
L. Mader and J. W. Keillor, RSC Med. Chem ., 2025 DOI: 10.1039/D5MD00050E Potent reversible covalent inhibitors are often slow in establish...
-
Yoav Shamir, Nir London bioRxiv 2025.03.19.642201 doi: https://doi.org/10.1101/2025.03.19.642201 Recent years have seen an explosion in the...